Guilin Sanjin Pharmaceutical Co Ltd (002275.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000DY9
Guilin Sanjin Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.19 bn CNY | 2.05 bn CNY |
| Gross profit | 1.58 bn CNY | 1.56 bn CNY |
| Operating income | 644.77 m CNY | 568.15 m CNY |
| EBIT | 480.47 m CNY | 556.78 m CNY |
| Net income | 521.53 m CNY | 433.13 m CNY |
| Diluted EPS – continuing operations | 0.89 CNY | 0.74 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Guilin Sanjin Pharmaceutical Co Ltd
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, manufacturing, and sale of traditional Chinese medicines in China and internationally. The company offers Sanjin Tablets, Sanjinpian, Guilin Watermelon Frost, Watermelon Frost Throat Lozenges, Guilin Watermelon Frost Lozenges, Watermelon Frost Throat Clearing Lozenges, Vertigo Relief Tablets/Granules, Gecko Asthma Relief Capsules, Lamotrigine Tablets (Anxian), Naomaitai Capsules, Yuye Detoxification Granules, and Compound Tianqi Stomach Pain Capsules, Soothing Throat Spray, Guilin Watermelon Frost Capsules, NaoMaiTai Capsules, Dizziness Relief Granules, Sanqi Blood Damage Relief Capsules, Sanqi Blood Injury Relief Powder, Compound Luo Han Guo Lung-Clearing Granules, Compound Monk Fruit Lung-Clearing Syrup, Compound Red Root Herb Tablets, Shuanghu Swelling and Pain Relief, Liver and Kidney Tonifying Granules, and Jade Leaf Detoxification Granules. Its products are used in various therapeutic areas, such as urinary system diseases, oral and pharyngeal medications, throat medication, cardiovascular and cerebrovascular disease medications, nervous system diseases, respiratory disease, digestive system disease, internal medicine drugs, musculoskeletal system diseases, and tonifying drugs. Guilin Sanjin Pharmaceutical Co., Ltd. was incorporated in 2001 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.
More stocks
- Hubei TKD Crystal Electn (603738.SS)
- Birchcliff Energy Ltd (BIR.TO)
- Trustpilot Group PLC (TRST.L)
- GoTo Gojek Tokopedia PT (GOTO.JK)
- ICHOR HOLDINGS, LTD. (ICHR)
- Playtech PLC (PTEC.L)
- Savaria Corp (SIS.TO)
- Opmobility SE (OPM.PA)
- Snowline Gold Corp (SGD.TO)
- Xi An Triangle Defens Co Ltd (300775.SZ)
- Hongrun Construction Group Co Ltd (002062.SZ)
- Pacira BioSciences, Inc. (PCRX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.